Concepedia

Noelia Silva-Pilipich

NS

Statistics

Publications

6

Citations

153

H-Index

6

Active since

2019

Affiliations

Universidad de Navarra(Current)

Navarre Institute of Health Research

Clinica Universidad de Navarra

Navarrabiomed

Universidad ORT Uruguay

Noelia Silva-Pilipich is an author at Universidad de Navarra specializing in cancer immunotherapy, oncology, and immune checkpoint inhibitors.

ORCID

Publications per year

2019–2025

6

Publications

6

Intratumoral electroporation of a self-amplifying RNA expressing IL-12 induces antitumor effects in mouse models of cancer

Noelia Silva-Pilipich, Aritz Lasarte-Cía, Teresa Lozano et al. · Molecular Therapy — Nucleic Acids · 2022 · 49 citations · Full text

, , +12

Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses

María Cristina Ballesteros-Briones, Eva Martišová, Erkuden Casales et al. · Molecular Therapy · 2019 · 41 citations · Full text

, , +17

Long-Term Systemic Expression of a Novel PD-1 Blocking Nanobody from an AAV Vector Provides Antitumor Activity without Toxicity

Noelia Silva-Pilipich, Eva Martišová, María Cristina Ballesteros-Briones et al. · Biomedicines · 2020 · 21 citations · Full text

, , +17

Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses

Noelia Silva-Pilipich, Ester Blanco, Teresa Lozano et al. · Cancer Letters · 2023 · 18 citations · Full text

, , +17

Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies

Ester Blanco, Noelia Silva-Pilipich, Ana Bocanegra et al. · British Journal of Cancer · 2024 · 13 citations · Full text

, , +17

1–5 of 6